ERYTHROPOIESIS ABNORMAL side effect
What is ERYTHROPOIESIS ABNORMAL ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
ERYTHROPOIESIS ABNORMAL and Recently Reported Side Effects
ERYTHROPOIESIS ABNORMAL and 15 most Active Side Effect polls
ERYTHROPOIESIS ABNORMAL and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with ERYTHROPOIESIS ABNORMAL
ARANESP AUGMENTIN EXJADE IMATINIB ROSIGLITAZONE TOSITUMOMAB TRIMETHOPRIM VINCRISTINETositumomab Side Effects Report #5407108-2
Consumer or non-health professional from UNITED STATES reported TOSITUMOMAB problem on July 24, 2007. Male patient, 50 years of age, was treated with TOSITUMOMAB. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, myelodysplastic syndrome, thrombocytopenia, . TOSITUMOMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE, RITUXAN, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient recovered.
Exjade Side Effects Report #5780261-7
EXJADE problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2008. Male patient, weighting 167.6 lb, was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, transfusion, . EXJADE dosage: 1000 MG, QD. Patient recovered.
Trimethoprim Side Effects Report #5458142-8
Consumer or non-health professional from UNITED KINGDOM reported TRIMETHOPRIM problem on Sept 03, 2007. Female patient was treated with TRIMETHOPRIM. After drug was administered, patient experienced the following problems/side effects: anaemia, erythropoiesis abnormal, vasculitic rash, . TRIMETHOPRIM dosage: 100 MG (100 MG, 1 IN 1 D) ORAL. Patient recovered.
Aranesp Side Effects Report #5378842-8
ARANESP problem was reported by a Health Professional from UNITED STATES on June 26, 2007. Male patient, weighting 218.5 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, hospitalisation, therapeutic response decreased, . ARANESP dosage: unknown. During the same period patient was treated with LASIX, DARVOCET, DOXAZOSIN MESYLATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5378842-8
Health Professional from UNITED STATES reported ARANESP problem on June 26, 2007. Male patient, weighting 218.5 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, hospitalisation, therapeutic response decreased, . ARANESP dosage: unknown. During the same period patient was treated with LASIX, DARVOCET, DOXAZOSIN MESYLATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Vincristine Side Effects Report #5712902-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, erythropoiesis abnormal, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Imatinib Side Effects Report #5430651-7
Consumer or non-health professional from SPAIN reported IMATINIB MESYLATE problem on Aug 08, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia, . IMATINIB MESYLATE dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, INTERFERON ALFA. Patient recovered.
Rosiglitazone Side Effects Report #5736907-2
ROSIGLITAZONE MALEATE problem was reported by a Consumer or non-health professional from ITALY on Apr 28, 2008. Male patient, 47 years of age, was diagnosed with secondary immunodeficiency and was treated with ROSIGLITAZONE MALEATE. After drug was administered, patient experienced the following problems/side effects: anaemia, erythropoiesis abnormal, . ROSIGLITAZONE MALEATE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE, NIFEDIPINE, FUROSEMIDE, BICARBONATE, ALLOPURINOL, RAMIPRIL, CALCITRIOL. Patient recovered.
Augmentin Side Effects Report #5704430-7
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Apr 04, 2008. Male patient, 78 years of age, was diagnosed with febrile infection and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow myelogram abnormal, erythropoiesis abnormal, haemoglobin decreased, neutrophil count decreased, pancytopenia, platelet count decreased, red blood cell count decreased, thrombocytopenia, . AUGMENTIN dosage: unknown. During the same period patient was treated with XATRAL, PROSCAR, TOPALGIC, CALCIPARINE, COZAAR, PLAVIX, OMEPRAZOLE, ALPRAZOLAM. Patient was hospitalized. Patient recovered.